EU cross-border healthcare directive will have fundamental impact on medtech industry
This article was originally published in RAJ Devices
Executive Summary
The EU's directive on the application of patients' rights in cross-border healthcare will have a fundamental impact on the medtech market of the future1,2. New structures created by the directive will particularly affect the areas of health technology assessment, e-health and the co-ordination of healthcare specialisations, particularly for rare diseases.